DrugPatentWatch Database Preview

APRACLONIDINE HYDROCHLORIDE - Generic Drug Details

What are the generic drug sources for apraclonidine hydrochloride and what is the scope of apraclonidine hydrochloride patent protection?

Apraclonidine hydrochloride is the generic ingredient in two branded drugs marketed by Akorn Inc and Novartis Pharms Corp, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for apraclonidine hydrochloride. Three suppliers are listed for this compound.

Summary for APRACLONIDINE HYDROCHLORIDE

US Patents:	0
Tradenames:	2
Applicants:	2
NDAs:	3
Drug Master File Entries:	3
Suppliers / Packagers:	3
Bulk Api Vendors:	56
Clinical Trials:	1
Patent Applications:	283
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for APRACLONIDINE HYDROCHLORIDE
DailyMed Link:	APRACLONIDINE HYDROCHLORIDE at DailyMed

Pharmacology for APRACLONIDINE HYDROCHLORIDE

Drug Class	alpha-Adrenergic Agonist
Mechanism of Action	Adrenergic alpha-Agonists

Synonyms for APRACLONIDINE HYDROCHLORIDE

1,4-Benzenediamine, 2,6-dichloro-N(sup 1)-(4,5-dihydro-1H-imidazol-2-yl)-, monohydrochloride
1,4-Benzenediamine, 2,6-dichloro-N(sup 1)-2-imidazolidinylidene-, monohydrochloride
2-((4-Amino-2,6-dichlorophenyl)imino)imidazolidine monohydrochloride
2-(4-Amino-2,6-dichloroanilino)-2-imidazoline hydrochloride
2-(4-Amino-2,6-dichlorophenylimino)imidazolidine hydrochloride
2-[(2,6-dichloro-4-aminophenyl)imino]imidazolidine hydrochloride
2,6-bis(chloranyl)-N1-(4,5-dihydro-1H-imidazol-2-yl)benzene-1,4-diamine hydrochloride
2,6-dichloro-1-N-(4,5-dihydro-1H-imidazol-2-yl)benzene-1,4-diamine hydrochloride
2,6-Dichloro-N(1)-(2-imidazolidinylidene)-1,4-benzenediamine hydrochloride
2,6-Dichloro-N(1)-(4,5-dihydro-1H-imidazol-2-yl)-1,4-benzenediamine monohydrochloride
2,6-Dichloro-N(sup 1)-(2-imidazolidinylidene)-1,4-benzenediamine hydrochloride
2,6-Dichloro-N(sup 1)-(4,5-dihydro-1H-imidazol-2-yl)-1,4-benzenediamine monohydrochloride
2,6-Dichloro-N1-(4,5-dihydro-1H-imidazol-2-yl)-1,4-benzenediamine Hydrochloride
2,6-dichloro-N1-(4,5-dihydro-1H-imidazol-2-yl)benzene-1,4-diamine hydrochloride
218A798
3,5-Dichloro-4-(2-imidazolidinylidenimino)aniline hydrochloride
4CH-016312
73218-79-8
87913-86-8
A 0779
A837749
AC-12705
AC1L1BOD
AK143283
AKOS022175501
AKOS025401362
AL 02145
AL-02145
ALO-2145
AN-6532
Aplonidine HCl
Aplonidine hydrochloride
Apraclonidine hydrochloride
Apraclonidine HCl
Apraclonidine hydrochloride (JAN/USP)
Apraclonidine hydrochloride [USAN]
Apraclonidinehydrochloride
BG0575
C-17735
C9H10Cl2N4.HCl
C9H11Cl3N4
CAS-73218-79-8
CC-24163
CCG-221337
CHEBI:2789
CHEMBL1200379
CTK8F7806
D01008
D2VW67N38H
DR000985
DSSTox_CID_25749
DSSTox_GSID_45749
DSSTox_RID_81093
DTXSID6045749
EU-0100033
FT-0602878
Iopidine ophthalmic solution
KS-00000MLM
LP00033
LS-29586
MFCD00135922
MLS000028829
MLS006010230
MolPort-006-069-427
NC 14 hydrochloride
NCGC00093552-01
NCGC00260718-01
OTQYGBJVDRBCHC-UHFFFAOYSA-N
p-Aminoclonidine hydrochloride
p-Aminoclonidine hydrochloride, solid
p-Aminoclonidine Monohydrochloride
S311
SCHEMBL41138
SMR000058965
SR-01000075247
SR-01000075247-1
ST2409192
Tox21_111207
Tox21_500033
UNII-D2VW67N38H

US Patents and Regulatory Information for APRACLONIDINE HYDROCHLORIDE

+ Get email alerts for changes to this table

Glossary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novartis Pharms Corp	IOPIDINE	apraclonidine hydrochloride	SOLUTION/DROPS;OPHTHALMIC	020258-001	Jul 30, 1993	AT	RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Novartis Pharms Corp	IOPIDINE	apraclonidine hydrochloride	SOLUTION/DROPS;OPHTHALMIC	019779-001	Dec 31, 1987		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Akorn Inc	APRACLONIDINE HYDROCHLORIDE	apraclonidine hydrochloride	SOLUTION/DROPS;OPHTHALMIC	077764-001	Mar 12, 2009	AT	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for APRACLONIDINE HYDROCHLORIDE

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis Pharms Corp	IOPIDINE	apraclonidine hydrochloride	SOLUTION/DROPS;OPHTHALMIC	020258-001	Jul 30, 1993	➤ Sign Up	➤ Sign Up
Novartis Pharms Corp	IOPIDINE	apraclonidine hydrochloride	SOLUTION/DROPS;OPHTHALMIC	019779-001	Dec 31, 1987	➤ Sign Up	➤ Sign Up
Novartis Pharms Corp	IOPIDINE	apraclonidine hydrochloride	SOLUTION/DROPS;OPHTHALMIC	019779-001	Dec 31, 1987	➤ Sign Up	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration